chartexchange

RDHL
Redhill Biopharma Ltd.
stockNASDAQADR

Market OpenOct 29, 2026 10:06:42 AM EDT
0.39USD-7.921%(-0.03)79,568
0.3700Bid0.5600Ask0.1900Spread
Loading…
Loading…
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
Dror Ben-Asher
HQ
Tel Aviv, Tel Aviv Yafo, Israel
Previous Close
$0.43
Beta
0.67
52-Week High
$1.60 2026-08-31
52-Week Low
$0.39 2026-10-26
SMA 50
$0.57
SMA 200
$0.82
Avg. Vol 10D
133,789
Avg. Vol 30D
662,319
Avg. Vol 90D
1.49M
Relative Vol
0.12
2.28M
49.1100%
300
Aug 20, 2024 · 1-for-25 (reverse)
RDHL Profile

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise

RDHL Performance
PeriodPriceDateChangeBeta
1W0.422026-10-22-3.96%1.035
1M0.482026-09-29-15.77%0.883
3M0.682026-07-29-40.63%-0.020
6M1.042026-04-29-61.02%0.052
1Y1.462025-10-29-72.23%0.671
2Y8.012024-10-29-94.94%—
5Y5,440.002021-10-29-99.99%1.032
RDHL Stock Summary

Redhill Biopharma Ltd. (NASDAQ:RDHL) stock price today is $0.41, and today's volume is 79,227. RDHL is down 5.280% today. The 30 day average volume is 662,319. RDHL market cap is $3.60M with 8.89M shares outstanding.